SLC39A8 and colitis: The Slc39a8-IEC KO mice developed clinical symptoms of colitis with increasing severity starting on day 2 of the second cycle and peaking on day 11, whereas the symptoms in control mice were delayed and significantly reduced in severity (Fig. 5b).